Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-042022
Filing Date
2021-02-16
Accepted
2021-02-12 18:24:38
Documents
2
Group Members
COLUMN GROUP II GP, LPDAVID GOEDDELPETER SVENNILSON

Document Format Files

Seq Description Document Type Size
1 SC 13G d120354dsc13g.htm SC 13G 85050
2 EX-99.1 d120354dex991.htm EX-99.1 6584
  Complete submission text file 0001193125-21-042022.txt   93271
Mailing Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 4158652050
COLUMN GROUP II, LP (Filed by) CIK: 0001600420 (see all company filings)

EIN.: 211417046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Subject) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91490 | Film No.: 21630688
SIC: 2834 Pharmaceutical Preparations